FDA Investigator Sena G Dissmeyer

Sena G Dissmeyer has inspections in 9 countries as of 29 Aug 2023. Sena G Dissmeyer has collaborated with a combinined 3872 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
53
Last Inspection Date:
29 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Greece, China, Canada, United Kingdom of Great Britain and Northern Ireland, Taiwan, Japan, Malta, Israel
Co-Investigator(s):
Ademola O Daramola, Adetutu M Gidado, Aimee Cunningham, PhD, Amanda M Osteen, Amy N Chen, Anastasia M Shields, Anh M Lac, Anita R Michael, Anne L Aberdeen, Annemarie Bodnar, Annet R Rajan, Anthony F Lorenzo, Anthony W Lee, Arie C Menachem, Arsen Karapetyan, Ashley L Reiber, Austin B Appler, Barbara J Rincon, Barbara Jwilimczyk Macri, Bijoy Panicker, Brandy N Lepage, Brian D Nicholson, Brooke K Higgins, Brooke K Secman, Candice C Mandera, Candice J Cortes, Carole L Jones, Caryn M Mcnab, Chaltu N Wakijra, Charisse K Green, Charles E Idjagboro, Christina K Theodorou, Christopher L Taste, Christopher T Middendorf, Concepcion Cruz, Jr, Constance Y Fears, Craig D Zagata, David A Oluwo, David J Hafner, David P Rice, Derek S Smith, PhD, Deyaa Shaheen, Diane L Raccasi, Diane T Bargo, Diane T O'bien, Diane T O'brien, Dianne S Alexander, Djamila Harouaka, Douglas A Campbell, Douglas C Kovacs, Dr. Ralph M Bernstein, PhD, Dr. Sriram Subramaniam, PhD, Elvis D Morton, Emest F Bizjak, Emilie E Kahn, Ephrem Hunde, PhD, Eric Rothschild, Erika V Butler, Erin L Mcfiren, Frederick Razzaghi, Gale L Glinecki, George Pyramides, Gerald B Seaborn, Jr, Geraldine D Sanders, Haoheng Yan, PhD, Helen Verdel, Himanshu Gupta, PhD, Holly S Simms, Hongna Wang, Howard Anderson, PhD, Ivy E Sweeney, Jacqueline Johnson, Jacqueline Mdiaz Albertini, Jacquelyn D Hokamp, Jacquelyn Gess, Jai P Singh, Jaison J Eapen, James M Mason, James M Simpson, James W Leonette, Janet A Rajan, Jay T Wong, Jennifer Swisher, PhD, Jesse P Hardin, Jessica D Weber, Jessica Hankins, PhD, Jessica S Estriplet, Jogy George, John Dan, Jonathan W Chapman, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose M Cayuela, Jose R Hernandez, Joseph L Despins, PhD, Joseph T Dougherty, Joshua P Wireman, Juliana M Badalucco, Julie A Silberberg, Junho Pak, Justin A Boyd, Kalavati Suvarna, PhD, Kara D Dobbin, Karen A Briggs, Karen E D'orazio, Karishma G Gopaul, Kathleen M Jordan, Kelly L Anderson, Kenneth Nieves, Kham Phommachanh, Ko U Min, Lata C Mathew, PhD, Lauren L Vajo, LCDR Cornelius Brown, III, LCDR Debra Emerson, LCDR Wilfred A Darang, Li Lu, PhD, Liatte Kreuger, PharmD, Libia M Lugo, Lisa R Hilliar, Lloyd D Payne, Lori S Lawless, Lynette P Salisbury, Malgorzata G Norton, Marcellinus D Dordunoo, Marcia D Fields, Marcus A Ray, Margaret M Sands, Maria Joselopez Barragan, PhD, Marion Michaelis, Maureen A Wentzel, Melissa J Garcia, Meredith L Sheridan, Merideth K Rose, Michael J Vardon, Michael R Klapal, Mindy M Chou, Mohamad A Chahine, Mra Narulaa, Nancy F Scheraga, Nancy M Espinal, Nancy Sheraga, Natasha A Dezinna, Natasha Gupta, Nebil A Oumer, Nicholas A Violand, Nicole E Knowlton, Nicole K Trudel, Olaide Akinmade, Omotunde O Osunsanmi, Patsy J Domingo, Paul L Bellamy, Peter C Chow, Prabhu P Raju, Pratik S Upadhyay, DDC, Qin Xu, Quyen T Tran, Rachel C Harrington, Rafael E Arroyo, Ramon A Hernandez, Regina Gibson Melton, Richard W Thornton, Robert J Martin, Robert L Lewis, Jr, Rose M Ashley, Roseline N Boateng, Roy R Rinc, Russell J Glapion, Sachinkumar V Patel, Saleem A Akhtar, Sandra A Boyd, Santos E Camara, Sarah E Mcmullen, Senz G Dissmeyer, Shirley S Wen, Shusheen A Alexander, Srinivas R Chennamaneni, PhD, State Agency, Stephanie L Shapley, Steven Kozlowski, MD, Steven P Donald, Susan F Laska, MS, Susanna E Ford, Analyst, Suzanne M Healy, Suzanne Suzanne, Taichun Qin, PhD, Tajah L Blackburn, Tamal K Chakraborti, PhD, Tanya R Syffrard, Tekalign Wondimu, Teresa I Navas, Thomas E Friel, Tonia F Bernard, Toyin B Oladimeji, Unnee Ranjan, Valeria A Moore, Valerie L Whipp, Vilmary Negron Rodriguez, Viviana Matta, Vlada Matusovsky, Walter Fava, Walter L Fava, William A Warnick, William C Brenneman, William H Linkroum, William J Leonard, William J Muszynski, Xu Michael Di, PhD, Yasamin Ameri, Yumi J Hiramine, Yvesna C Blaise, Zakaria I Ganiyu, Zhao Wang, PhD, Zhong Li, PhD, Zhongren Wu

Sena G Dissmeyer's Documents

Publish Date Document Type Title
June, 2019 EIR Fisher BioServices - EIR, 2019-06-28
September, 2021 FDA 483 Boothwyn Pharmacy LLC - Form 483, 2021-09-08
January, 2020 EIR Granules Pharmaceuticals Inc. - EIR, 2020-01-17
September, 2018 FDA 483 Arnold Professional Pharmacy - Form 483, 2018-09-05
May, 2022 FDA 483 Aphena Pharma Solutions - Maryland, LLC - Form 483, 2022-05-06
September, 2019 FDA 483 Luohe Nanjiecun Pharmaceutical Group Pharmacy Co.,Ltd. - Form 483, 2019-09-27
October, 2021 FDA 483 InfuScience, Inc. dba Bioscrip Infusion Services - Form 483, 2021-10-08
August, 2018 FDA 483 PharmScript, LLC - Form 483, 2018-08-07
April, 2017 EIR Cheng Fong Chemical Co., Ltd. Dayuan Factory - EIR, 2017-04-14
August, 2017 FDA 483 Suco Inc - Form 483, 2017-08-02
January, 2023 FDA 483 AstraZeneca Pharmaceuticals LP - Form 483, 2023-01-19
June, 2021 FDA 483 Granules Pharmaceuticals Inc. - Form 483, 2021-06-25
August, 2022 FDA 483 ImprimisRx NJ - Form 483, 2022-08-05
February, 2022 FDA 483 Cangene BioPharma, LLC - Form 483, 2022-03-15
September, 2019 FDA 483 Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd. - Form 483, 2019-09-20
March, 2022 FDA 483 Arnold Professional Pharmacy - Form 483, 2022-03-18
October, 2017 FDA 483 Diversified Chemical Products - Form 483, 2017-10-25
July, 2019 FDA 483 InfuScience, Inc. dba Bioscrip Infusion Services - Form 483, 2019-07-30
December, 2022 FDA 483 Sentara Infusion Services - Form 483, 2022-12-16
December, 2017 FDA 483 Professional Arts Pharmacy - Form 483, 2017-12-12
February, 2022 FDA 483 Response Cangene BioPharma, LLC - Form 483R, 2022-03-10
May, 2022 FDA 483 Kinbio LTD - Form 483, 2022-05-26
January, 2020 FDA 483 Granules Pharmaceuticals Inc. - Form 483, 2020-01-17
August, 2017 FDA 483 BAYER HEALTHCARE LLC - Form 483, 2017-08-11
February, 2019 FDA 483 NOXELL CORPORATION - Form 483, 2019-02-25
December, 2021 FDA 483 Valgene Incorporated dba Cape Drugs - Form 483, 2021-12-02
September, 2022 FDA 483 Curexa - East, LLC dba Curexa - Form 483, 2022-09-09
April, 2019 EIR PHARMATHEN INTERNATIONAL S.A. - EIR, 2019-04-19
July, 2019 FDA 483 Keystone Rx LLC - Form 483, 2019-07-12

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more